Literature DB >> 22253443

Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.

Hongping Xia1, William K C Cheung, Samuel S Ng, Xiaochun Jiang, Songshan Jiang, Johnny Sze, Gilberto K K Leung, Gang Lu, Danny T M Chan, Xiu-Wu Bian, Hsiang-fu Kung, Wai Sang Poon, Marie C Lin.   

Abstract

miR-124 is a brain-enriched microRNA that plays a crucial role in neural development and has been shown to be down-regulated in glioma and medulloblastoma, suggesting its possible involvement in brain tumor progression. Here, we show that miR-124 is down-regulated in a panel of different grades of glioma tissues and in all of the human glioma cell lines we examined. By integrated bioinformatics analysis and experimental confirmation, we identified SNAI2, which is often up-regulated in glioma, as a direct functional target of miR-124. Because SNAI2 has been shown to regulate stem cell functions, we examined the roles of miR-124 and SNAI2 in glioma cell stem-like traits. The results showed that overexpression of miR-124 and knockdown of SNAI2 reduced neurosphere formation, CD133(+) cell subpopulation, and stem cell marker (BMI1, Nanog, and Nestin) expression, and these effects could be rescued by re-expression of SNAI2. Furthermore, enhanced miR-124 expression significantly inhibited glioma cell invasion in vitro. Finally, stable overexpression of miR-124 and knockdown of SNAI2 inhibited the tumorigenicity and invasion of glioma cells in vivo. These findings reveal, for the first time, that the tumor suppressor activity of miR-124 could be partly due to its inhibitory effects on glioma stem-like traits and invasiveness through SNAI2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253443      PMCID: PMC3322968          DOI: 10.1074/jbc.M111.332627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

Authors:  Fang Zheng; Yi-Ji Liao; Mu-Yan Cai; Yan-Hui Liu; Tian-Hao Liu; Shu-Peng Chen; Xiu-Wu Bian; Xin-Yuan Guan; Marie C Lin; Yi-Xin Zeng; Hsiang-Fu Kung; Dan Xie
Journal:  Gut       Date:  2011-06-14       Impact factor: 23.059

Review 2.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.

Authors:  Piyush B Gupta; Charlotte Kuperwasser; Jean-Philippe Brunet; Sridhar Ramaswamy; Wen-Lin Kuo; Joe W Gray; Stephen P Naber; Robert A Weinberg
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

4.  SLUG in cancer development.

Authors:  Pedro Antonio Pérez-Mancera; Inés González-Herrero; María Pérez-Caro; Noelia Gutiérrez-Cianca; Teresa Flores; Alfonso Gutiérrez-Adán; Belén Pintado; Manuel Sánchez-Martín; Isidro Sánchez-García
Journal:  Oncogene       Date:  2005-04-28       Impact factor: 9.867

5.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

Review 6.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

7.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

8.  Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice.

Authors:  L I de Ridder; O D Laerum; S J Mørk; D D Bigner
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  79 in total

Review 1.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  Microenvironmental regulation of cancer metastasis by miRNAs.

Authors:  Yun Zhang; Pengyuan Yang; Xiao-Fan Wang
Journal:  Trends Cell Biol       Date:  2013-10-11       Impact factor: 20.808

3.  MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.

Authors:  Zhu-Mei Shi; Xie-Feng Wang; Xu Qian; Tao Tao; Lin Wang; Qiu-Dan Chen; Xi-Rui Wang; Lei Cao; Ying-Yi Wang; Jun-Xia Zhang; Tao Jiang; Chun-Sheng Kang; Bing-Hua Jiang; Ning Liu; Yong-Ping You
Journal:  RNA       Date:  2013-02-21       Impact factor: 4.942

4.  Polypyrimidine tract-binding protein blocks miRNA-124 biogenesis to enforce its neuronal-specific expression in the mouse.

Authors:  Kyu-Hyeon Yeom; Simon Mitchell; Anthony J Linares; Sika Zheng; Chia-Ho Lin; Xiao-Jun Wang; Alexander Hoffmann; Douglas L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-06       Impact factor: 11.205

5.  Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.

Authors:  M H Shahi; S Farheen; M P M Mariyath; J S Castresana
Journal:  Tumour Biol       Date:  2016-09-23

6.  miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

Authors:  Lei Shi; Zhimin Wang; Guan Sun; Yi Wan; Jun Guo; Xingli Fu
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

7.  Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.

Authors:  Xinlong Ma; Koji Yoshimoto; Yaulei Guan; Nobuhiro Hata; Masahiro Mizoguchi; Noriaki Sagata; Hideki Murata; Daisuke Kuga; Toshiyuki Amano; Akira Nakamizo; Tomio Sasaki
Journal:  Neuro Oncol       Date:  2012-07-27       Impact factor: 12.300

8.  mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells.

Authors:  Daming Zhang; Guang Yang; Xin Chen; Chunmei Li; Lu Wang; Yaohua Liu; Dayong Han; Huailei Liu; Xu Hou; Weiguang Zhang; Chenguang Li; Zhanqiang Han; Xin Gao; Shiguang Zhao
Journal:  J Mol Neurosci       Date:  2014-01-28       Impact factor: 3.444

9.  PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.

Authors:  Xue Liu; Qian Chen; Xu-Gang Hu; Xian-Chao Zhang; Ti-Wei Fu; Qing Liu; Yan Liang; Xi-Long Zhao; Xia Zhang; Yi-Fang Ping; Xiu-Wu Bian
Journal:  Tumour Biol       Date:  2016-07-27

Review 10.  MicroRNAs in cancer stem cells: current status and future directions.

Authors:  Ravindresh Chhabra; Neeru Saini
Journal:  Tumour Biol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.